Overall survival better in advanced Hodgkin lymphoma with shorter eBEACOPPJune 24, 2017Lymphoma & Plasma Cell Disorders
Major bleeding deaths may outweigh VTE risk in older cancer patientsJune 24, 2017Patient & Survivor Care
Gilteritinib shows safety, efficacy in relapsed/refractory AMLJune 24, 2017Leukemia, Myelodysplasia, Transplantation
Infections may trigger leukemia in the genetically susceptibleJune 23, 2017Leukemia, Myelodysplasia, TransplantationPediatrics
Optimizing therapy in relapsed CLL: ibrutinib and beyondJune 23, 2017Leukemia, Myelodysplasia, Transplantation
Twofer drug blocks SYK/JAK pathways in advanced NHLJune 23, 2017Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Patch is early indicator of temperature rise after HSCTJune 23, 2017Leukemia, Myelodysplasia, Transplantation
Antibody from AML survivor may prove therapeuticJune 23, 2017Leukemia, Myelodysplasia, Transplantation
FDA approves rituximab + hyaluronidase human for FL, DLBCL, and CLLJune 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersFollicular Lymphoma
Lenalidomide consolidation linked to extended overall survival in non-del(11q) CLLJune 22, 2017Leukemia, Myelodysplasia, Transplantation
Bendamustine plus rituximab may have edge for treating indolent NHL, MCLJune 22, 2017Lymphoma & Plasma Cell Disorders
